The shelf offering isn't a risk. Not having access to it was.
Be sure your cannabis investments have the right CBD strategy, as the market for these products takes off.
This is a bullish market that -- rather than celebrating a dovish Fed and new highs -- fears missing out.
The loss of clients is a primary concern here.
Let's look at the chart of CRON.
The business continues to churn forward as the company announced it has achieved a full run-rate production of 75K kg at its Delta 3 greenhouse.
A cannabis-related REIT soared 172% in the first half of the year while a cloud services provider was up 53%, with more gains expected.
Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.
CEO MIke DeGiglio on the company's long history as a greenhouse grower, its biggest opportunities, Canadian joint venture Pure Sunfarms, and its footprint in one the best growing climates in the U.S. for cannabis.
Let's examine the latest charts and indicators.
CEO Derek Peterson on how a surfing accident led to the company's founding, being the first plant-touching company to go public, competition and the next big cannabis opportunity.
This natural and organic cultivation inputs company has the leading biological brand in the market - Mammoth.
Here's how to play OGI stock right now.
Let's take a look at the charts.
Recently public company is the leading distributor of premium vaporization products and consumption accessories in the U.S.
Still, the firm rates the companies mentioned as speculative buys.
Management's disappointment in Canopy Growth is akin to a coach expressing his displeasure with a prized rookie.
Let's see if we can identify the next sustained move.
It is important to expand your understanding beyond a few companies or a single concept.
Changes will come as they move their wine and spirits business to the 'high end', and develop the activities of Canopy Growth, which promises cannabis-infused drinks.
Two of them are brand new.
Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?
At first glance, CGC's report looks like a drag, but you must dig into the weeds to see how timing and the industry are at play.
Canopy Growth's latest financial results offer a reality check.
Canopy's earnings losses could just be a stepping stone to becoming the industry leader.
The cannabis company's performance as outlined in its year-end report should not inspire investor confidence.
While the cannabis company's stock is sliding on its year-end report, at least one analyst sees a long-term buying opportunity.
There's no way to play the stock of the meat alternative provider unless you are a kamikaze daredevil with a very deep pocketbook.
If cannabis is descheduled, it is likely it will become federally regulated -- and convenience stores are preparing their case for selling it like tobacco products.
Let's look at the charts this morning.